Ibrutinib-associated hemophagocytic lymphohistiocytosis: A case series from Johns Hopkins.

Ambinder, Alexander J; Hambley, Bryan; Shanbhag, Satish; Merrill, Samuel A

Ambinder, Alexander J; Hambley, Bryan; Shanbhag, Satish; Merrill, Samuel A.

Affiliation

Ambinder AJ; Division of Hematology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Hambley B; Division of Hematology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Shanbhag S; Division of Hematology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Merrill SA; Division of Hematology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Am J Hematol ; 94(11): E296-E299, 2019 11.

Article in En | MEDLINE | ID: mdl-31400009

Subject(s)

Antineoplastic Agents/adverse effects; Lymphohistiocytosis, Hemophagocytic/chemically induced; Pyrazoles/adverse effects; Pyrimidines/adverse effects; Adenine/analogs & derivatives; Aged; Antineoplastic Agents/therapeutic use; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell/complications; Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy; Lymphohistiocytosis, Hemophagocytic/blood; Male; Middle Aged; Piperidines; Pyrazoles/therapeutic use; Pyrimidines/therapeutic use; Salvage Therapy; Waldenstrom Macroglobulinemia/complications; Waldenstrom Macroglobulinemia/drug therapy

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrazoles / Pyrimidines / Lymphohistiocytosis, Hemophagocytic / Antineoplastic Agents Type of study: Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Am J Hematol Year: 2019 Type: Article

Fulltext

XML

PubMed Links

Search on Google